Tag: BioTech

Hedge Funds and Investment Banks have literal teams of PhD Biochemists as Research Analysts and Portfolio Managers that have studied chemical compounds for years (trust me I know some of these individuals — you do NOT want to compete with them in a zero sum game that is the Stock Market). P...

This is my updated 2022 roundup of top resources in biotech, ruthlessly refined down to key sources from the comprehensive 2019 original. This list excludes many great ways to learn: conferences, scientific degrees, textbooks, talking with people or working in the sector. However, they’re t...

You might think you’re making new medicines, but if you’re a biotech startup, your primary deliverable over the next 5–10 years will be data. At every critical stage — from the weekly research meeting, to the CEO presenting to her board of directors, to the first IND ...

When I started at Longevity, my first task was to write an investment memo. I didn’t necessarily want to admit that I had no idea what an investment memo was, and especially no clue on how one writes such a thing. So I ran to the internet, found Sequoia’s YouTube IM, and promptly de...

Getting a biotech internship is hard. It can be easy to become dejected rejection after rejection and unlike other fields *cough* CS, biotech is pretty bare when it comes to internship application resources. On top of that, existing resources are pretty generic so I thought I’d share...

Many industries experience growth and advancement regularly. Therefore, they continuously seek the services of capable professionals to share their journey and the solutions they create with their target audience. It’s the same in biotechnology industries. Being a biotech writer means shari...

Despite being a nebulous and somewhat new role in the startup world, the Chief of Staff role is starting to be recognized and opined upon in a patently tech-forward Medium/Substack type of way — and even in the Harvard Business Review. My experience as Chief of Staff (CoS) to the Presi...

There have been many biotech breakthroughs over the past decade. Next come the regulatory approvals and the moneymaking products. One that caught my eye… The first-ever gene-editing (CRISPR) therapy was just approved in the US and the UK. CRISPR works like DNA scissors. It allows s...